Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1989-09-21
1991-03-05
Brown, Johnnie R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514 46, 514 47, 514 48, 514 49, 514 50, 514 51, A61K 3170
Patent
active
049978187
ABSTRACT:
A therapeutic method for specifically treating terminal deoxynucleotidyl transferase-positive neoplastic disease within living subjects is provided which is uniquely effective and selective. The therapeutic method comprises administering an effective concentration of a therapeutic composition to the subject, the therapeutic composition comprising a nitrogenous heterocyclic base selected from the group consisting of purines and purine derivatives and pyrimidines and pyrimidine derivatives; and a dideoxy-pentose monosaccharide moiety.
REFERENCES:
patent: 4151347 (1979-04-01), Umezawa et al.
patent: 4163839 (1979-07-01), Umezawa et al.
patent: 4576948 (1986-03-01), McCaffrey et al.
CA:104:17020v, Matthes et al. (1986).
Wagar et al., The Chemical Abstracts, 102:39565n (1985).
Dahlberg et al., The Chemical Abstracts, 107: 17299e (1987).
Plunkett et al., The Chemical Abstracts, 83: 172430v (1975).
Tyrsted et al., The Chemical Abstracts, 68: 76681x (1968).
Herdewijn et al., J. Med. Chem. 30, pp. 1270-1278 (1987).
McCaffrey Ronald P.
Spigelman Zachary
Brown Johnnie R.
Prashker David
The University Hospital
Wilson James O.
LandOfFree
Therapeutic method for selectively treating terminal deoxynucleo does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic method for selectively treating terminal deoxynucleo, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic method for selectively treating terminal deoxynucleo will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-496830